Loading clinical trials...
Loading clinical trials...
Non-steroidal Anti-inflammatory Drugs in Pleurodesis Surgery for Pneumothorax
Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended in a multimodal pain management to reduce pain intensity and to spare opioid use. However, there is a controversy in its use in pleurodesis surgery as it could block the process of pleurodesis in surgical pneumothorax. In addition, NSAIDs could increase the risk of pneumothorax recurrence. The investigators hypothesized that NSAIDs are safe during pleurodesis with a better pain management without increasing the risk of pneumothorax reccurence.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Centre Hospitalier Universitaire d'Amiens
Amiens, France
Start Date
February 1, 2025
Primary Completion Date
November 1, 2027
Completion Date
November 1, 2028
Last Updated
March 19, 2025
358
ESTIMATED participants
pleurodesis procedures
PROCEDURE
KETOPROFEN(RP19583)
DRUG
Placebo
DRUG
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Collaborators
NCT07186933
NCT06686251
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions